JP2003512446A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512446A5
JP2003512446A5 JP2001533091A JP2001533091A JP2003512446A5 JP 2003512446 A5 JP2003512446 A5 JP 2003512446A5 JP 2001533091 A JP2001533091 A JP 2001533091A JP 2001533091 A JP2001533091 A JP 2001533091A JP 2003512446 A5 JP2003512446 A5 JP 2003512446A5
Authority
JP
Japan
Prior art keywords
dihydro
alkyl
naphthalen
branched
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001533091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512446A (ja
Filing date
Publication date
Priority claimed from SE9903930A external-priority patent/SE9903930D0/xx
Application filed filed Critical
Publication of JP2003512446A publication Critical patent/JP2003512446A/ja
Publication of JP2003512446A5 publication Critical patent/JP2003512446A5/ja
Pending legal-status Critical Current

Links

JP2001533091A 1999-10-29 2000-10-26 ホスフィン配位子の存在下のロジウム触媒作用開環反応により製造された新規なヒドロナフタレン化合物 Pending JP2003512446A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9903930-7 1999-10-29
SE9903930A SE9903930D0 (sv) 1999-10-29 1999-10-29 Novel compounds and a novel process for their preparation
PCT/SE2000/002090 WO2001030734A1 (en) 1999-10-29 2000-10-26 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand

Publications (2)

Publication Number Publication Date
JP2003512446A JP2003512446A (ja) 2003-04-02
JP2003512446A5 true JP2003512446A5 (https=) 2007-12-20

Family

ID=20417551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001533091A Pending JP2003512446A (ja) 1999-10-29 2000-10-26 ホスフィン配位子の存在下のロジウム触媒作用開環反応により製造された新規なヒドロナフタレン化合物

Country Status (20)

Country Link
US (4) US6525068B1 (https=)
EP (2) EP1228024B1 (https=)
JP (1) JP2003512446A (https=)
KR (1) KR100741177B1 (https=)
CN (1) CN1231439C (https=)
AT (1) ATE275120T1 (https=)
AU (1) AU776118B2 (https=)
BR (1) BR0015117A (https=)
CA (1) CA2387675C (https=)
DE (1) DE60013471T2 (https=)
ES (1) ES2225253T3 (https=)
HK (1) HK1047083B (https=)
IL (2) IL149368A0 (https=)
MX (1) MXPA02004224A (https=)
NO (1) NO328015B1 (https=)
NZ (1) NZ518451A (https=)
PT (1) PT1228024E (https=)
SE (1) SE9903930D0 (https=)
WO (1) WO2001030734A1 (https=)
ZA (1) ZA200203050B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408689B8 (pt) * 2003-03-25 2021-05-25 Laboratoires Fournier S A derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
FR2852958B1 (fr) * 2003-03-25 2005-06-24 Fournier Lab Sa Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
PT1670458E (pt) 2003-10-08 2007-03-30 Schering Ag Derivados de tetra-hidronaftaleno, processo para a sua preparação e utilização como inibidor de inflamação
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102005017316A1 (de) * 2005-04-14 2006-10-19 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP1834948A1 (de) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP2070903A1 (en) 2007-12-12 2009-06-17 Laboratorios del Dr. Esteve S.A. Microwave-assisted ring opening reaction
EP2070904A1 (en) 2007-12-12 2009-06-17 Laboratorios Del. Dr. Esteve, S.A. Rhodium-phosphorus complexes and their use in ring opening reactions
KR101229822B1 (ko) 2008-03-04 2013-02-05 연세대학교 산학협력단 혈관신생 억제용 약제학적 조성물
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP5656364B2 (ja) * 2009-04-20 2015-01-21 株式会社トクヤマ ナフトピラン誘導体の製造方法
TWI481401B (zh) * 2010-01-27 2015-04-21 Takeda Pharmaceutical 藥劑
JP6236785B2 (ja) * 2012-02-28 2017-11-29 株式会社リコー アリールアミン化合物、有機el用材料およびその製造方法
CN105399752B (zh) * 2015-11-04 2019-03-15 云南民族大学 一种新型化合物及其制备方法和应用
US11560384B2 (en) 2017-05-04 2023-01-24 University Of Utah Research Foundation Benzonorbornadiene derivatives and reactions thereof
CN108863855B (zh) * 2018-05-29 2020-12-15 云南民族大学 一种合成(1r,2s)-1,2-二氢化萘-1,2-二胺衍生物的方法
CN111471005B (zh) * 2020-05-21 2023-04-07 南方科技大学 一种吲哚-二氢化萘类化合物及其制备方法和应用
CN116459873B (zh) * 2022-01-12 2025-02-18 万华化学集团股份有限公司 一种烯属不饱和化合物羰基化催化剂及其制备方法、应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4031097A (en) * 1997-08-27 1999-03-16 Kyowa Hakko Kogyo Co. Ltd. Process for preparing optically active 1,2-diols

Similar Documents

Publication Publication Date Title
JP2003512446A5 (https=)
CA2387675A1 (en) Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
AU691495B2 (en) MDR reversal agents
CN100453529C (zh) 芳基磺酰胺及其类似物及其在治疗神经变性疾病中的用途
RU2265599C2 (ru) Кристаллические соли 7-[4-(4-фторфенил)-6-изопропил-2-[метил (метилсульфонил) амино]пиримидин-5-ил]-(3r,5s)-3,5-дигидроксигепт-6-еновой кислоты, способ их получения и фармацевтическая композиция
WO2006024837A1 (en) Isoindolin-1-one derivatives
RU98102128A (ru) Производные бензо[g]хинолина
EP0379416A3 (fr) Dérivés d'azabicycloheptène et leurs sels, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
KR910006277A (ko) N-치환된-4-피리미딘아민 및 피리미딘디아민, 이의 제조방법 및 약제로서의 이의 용도
JP2003500399A (ja) 免疫抑制活性を有する置換フェニル化合物および医薬組成物
RU2005130514A (ru) 2,5- и 2,6-замещенные тетрагидроизохинолины, предназначенные для применения в качестве модуляторов 5-нт6
US12258308B2 (en) Benzene derivative
JPH06509813A (ja) メタロプロティナーゼ阻害剤としてのスルファミド誘導体
RS50561B (sr) Derivati sulfonamida za lečenje bolesti
TWI451865B (zh) 胺化合物及其醫藥用途
RU2004107261A (ru) Арилсульфонильные производные, обладающие сродством к рецептору 5-нт6
RU2005121125A (ru) Аминоалкоксииндолы, как лиганды рецептора 5-нт6, для лечения заболеваний цнс
CA2519110A1 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation dans le traitement de la douleur
WO2016196342A1 (en) Tetrasubstituted alkene compounds and their use
US20110092468A1 (en) Pharmaceutical Calcimimetics
CN101479231A (zh) 作为cox-2抑制剂的苯基乙酸衍生物
JP7384179B2 (ja) ベンゼン誘導体を含有する医薬組成物
AU1976500A (en) 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
BR112021001853B1 (pt) Compostos derivado de benzeno, sais dos mesmos, uso dos mesmos para prevenir ou tratar neuropatia, composição farmacêutica e agentes profiláctico e/ou terapêutico e para a promoção da diferenciação de células de schwann
JP2008509894A5 (https=)